» Articles » PMID: 32191399

Interleukin-36α As a Potential Biomarker for Renal Tubular Damage Induced by Dietary Phosphate Load

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2020 Mar 20
PMID 32191399
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive intake of phosphate has been known to induce renal tubular damage and interstitial inflammation, leading to acute kidney injury or chronic kidney disease in rodents and humans. However, sensitive and early biomarkers for phosphate-induced kidney damage remain to be identified. Our previous RNA sequencing analysis of renal gene expression identified interleukin-36α (IL-36α) as a gene significantly upregulated by dietary phosphate load in mice. To determine the time course and dose dependency of renal IL-36α expression induced by dietary phosphate load, we placed mice with or without uninephrectomy on a diet containing either 0.35%, 1.0%, 1.5%, or 2.0% inorganic phosphate for 10 days, 4 weeks, or 8 weeks and evaluated renal expression of IL-36α and other markers of tubular damage and inflammation by quantitative RT-PCR, immunoblot analysis, and immunohistochemistry. We found that IL-36α expression was induced in distal convoluted tubules and correlated with phosphate excretion per nephron. The increase in IL-36α expression was simultaneous with but more robust in amplitude than the increase in tubular damage markers such as Osteopontin and neutrophil gelatinase-associated lipocalin, preceding the increase in expression of other inflammatory cytokines, including transforming growth factor-α, interleukin-1β, and transforming growth factor-β1. We conclude that IL-36α serves as a marker that reflects the degree of phosphate load excreted per nephron and of associated kidney damage.

Citing Articles

Correlative light and electron microscopic observation of calcium phosphate particles in a mouse kidney formed under a high-phosphate diet.

Battulga B, Shiizaki K, Miura Y, Osanai Y, Yamazaki R, Shinohara Y Sci Rep. 2023; 13(1):852.

PMID: 36646820 PMC: 9842637. DOI: 10.1038/s41598-023-28103-3.


Klotho and calciprotein particles as therapeutic targets against accelerated ageing.

Kuro-O M Clin Sci (Lond). 2021; 135(15):1915-1927.

PMID: 34374422 PMC: 8355631. DOI: 10.1042/CS20201453.


Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.

Shiizaki K, Tsubouchi A, Miura Y, Seo K, Kuchimaru T, Hayashi H J Clin Invest. 2021; 131(16).

PMID: 34185705 PMC: 8363285. DOI: 10.1172/JCI145693.


Development of a Kidney Calcification Inhibitor Employing Image-Based Profiling: A Proof-of-Concept Study.

Kletzmayr A, Bigler M, Montanari E, Kuro-O M, Hayashi H, Ivarsson M ACS Pharmacol Transl Sci. 2020; 3(6):1339-1351.

PMID: 33344907 PMC: 7737319. DOI: 10.1021/acsptsci.0c00153.


Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis.

Melton E, Qiu H Int J Mol Sci. 2020; 21(18).

PMID: 32899668 PMC: 7556029. DOI: 10.3390/ijms21186458.

References
1.
Mori K, Lee H, Rapoport D, Drexler I, Foster K, Yang J . Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3):610-21. PMC: 548316. DOI: 10.1172/JCI23056. View

2.
Kelly D, Wilkinson-Berka J, Ricardo S, Cox A, Gilbert R . Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant. 2002; 17(6):985-91. DOI: 10.1093/ndt/17.6.985. View

3.
Lien Y . Is bowel preparation before colonoscopy a risky business for the kidney?. Nat Clin Pract Nephrol. 2008; 4(11):606-14. DOI: 10.1038/ncpneph0939. View

4.
Mo L, Liaw L, Evan A, Sommer A, Lieske J, Wu X . Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol. 2007; 293(6):F1935-43. DOI: 10.1152/ajprenal.00383.2007. View

5.
Kuro-O M . The Klotho proteins in health and disease. Nat Rev Nephrol. 2018; 15(1):27-44. DOI: 10.1038/s41581-018-0078-3. View